Jeevan Scientific Technology Ltd
NSE: BSE: 538837
₹62
(-2.99%)
Sat, 14 Mar 2026, 04:11 am
Market Cap1.27B
PE Ratio0
Dividend0
Health Services
Medical/Nursing Services
24.5KJeevan Scientific Technology Analysis
dividend
- Unable to evaluate Jeevan Scientific Technology's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.
- Unable to evaluate Jeevan Scientific Technology's dividend against the top 25% market benchmark as the company has not reported any payouts.
health
- Jeevan Scientific Technology is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
- Jeevan Scientific Technology has been profitable on average in the past, therefore cash runway is not a concern.
- Jeevan Scientific Technology has been profitable on average in the past, therefore cash runway is not a concern.
- Debt is covered by short term assets, assets are 1.4x debt.
- Jeevan Scientific Technology's cash and other short term assets cover its long term commitments.
- The level of debt compared to net worth has been reduced over the past 5 years (162.5% vs 63.1% today).
- Debt is not well covered by operating cash flow (18.6%, less than 20% of total debt).
- Jeevan Scientific Technology's level of debt (63.1%) compared to net worth is high (greater than 40%).
- High level of physical assets or inventory.
management
- The tenure for the Jeevan Scientific Technology board of directors is about average.
misc
- Jeevan Scientific Technology is not covered by any analysts.
past
- Unable to compare Jeevan Scientific Technology's 1-year earnings growth to the 5-year average as it is not currently profitable.
- Jeevan Scientific Technology does not make a profit and their year on year earnings growth rate was negative over the past 5 years.
- It is difficult to establish if Jeevan Scientific Technology has efficiently used its assets last year compared to the IN Life Sciences industry average (Return on Assets) as it is loss-making.
- It is difficult to establish if Jeevan Scientific Technology improved its use of capital last year versus 3 years ago (Return on Capital Employed) as it is currently loss-making.
- It is difficult to establish if Jeevan Scientific Technology has efficiently used shareholders’ funds last year (Return on Equity greater than 20%) as it is loss-making.
- Unable to compare Jeevan Scientific Technology's 1-year growth to the IN Life Sciences industry average as it is not currently profitable.
value
- Jeevan Scientific Technology is good value based on assets compared to the IN Life Sciences industry average.
- Jeevan Scientific Technology is loss making, we can't compare its value to the IN Life Sciences industry average.
- Jeevan Scientific Technology is loss making, we can't compare the value of its earnings to the India market.
- 538837 underperformed the Life Sciences industry which returned 36.1% over the past year.
- 538837 underperformed the Market in India which returned -14.5% over the past year.
- BSE:538837 is down -1.3% underperforming the Life Sciences industry which returned 2.6% over the past month.
- BSE:538837 is down -1.3% underperforming the market in India which returned 8% over the past month.
Open Your Free Demat Account Now!
Facebook
Twitter
Instagram
LinkedIn
Youtube
Calculators
Popular Calculators
Group Stocks
Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800